文献速递肝病消化道肿瘤与早癌

酒精相关性肝硬化中肝细胞癌发病率:系统评价与荟萃分析

Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-08-05

该研究系统检索至2021年8月,纳入18项研究共148,333例患者,采用随机效应模型汇总分析显示酒精相关性肝硬化1年、5年和10年肝细胞癌累积发病率分别为1%、3%和9%;参加肝癌监测项目的队列发病率更高(18.6 vs 4.8/1000人年,P=.001)。

要点

  • 酒精相关性肝硬化5年和10年肝细胞癌累积风险分别为3%和9%。
  • 参加肝癌监测项目的队列肝癌发病率高于未参加者(18.6 vs 4.8/1000人年,P=.001)。
  • 糖尿病、吸烟、静脉曲张出血和肝功能失代偿与肝癌风险升高相关。

核心结论

  • 酒精相关性肝硬化5年和10年肝细胞癌累积风险分别为3%和9%,参加肝癌监测项目的队列发病率更高。
  • 这些数据需在大型前瞻性研究中进一步验证,可能对酒精相关性肝硬化患者的肝癌筛查和监测有重要意义。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase、Cochrane Central Register、Scopus和Web of Science自建库至2021年8月。
  • 从已发表的Kaplan-Meier曲线重建个体患者数据,采用随机效应模型对肝细胞癌累积发病率进行汇总分析。
  • 共筛选5022篇文章,纳入18项研究,148,333例患者。

主要发现

  • 在考虑无肝癌死亡的竞争风险的研究中,酒精相关性肝硬化1年、5年和10年肝细胞癌累积发病率分别为1%、3%和9%。
  • 传统荟萃分析的二次分析显示,参加肝癌监测项目的队列肝细胞癌发病率高于未参加监测项目的队列(18.6 vs 4.8/1000人年;P=.001)。
  • 荟萃回归显示糖尿病、吸烟、静脉曲张出血和肝功能失代偿与肝细胞癌风险升高相关。

临床怎么用

  • 原文结论指出这些数据可能对酒精相关性肝硬化患者的肝癌筛查和监测有重要意义。

局限性

  • 原文结论指出这些数据需在大型前瞻性研究中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Alcohol is one of the leading causes of hepatocellular carcinoma (HCC). However, pooled estimates of HCC incidence in alcohol-associated cirrhosis have not been evaluated systematically. We performed a pooled analysis of time-to-event data to provide robust estimates for the incidence of HCC in alcohol-associated cirrhosis. METHODS: Medline, Embase, Cochrane Central Register, Scopus, and Web of Science were searched from inception to August 2021. Individual patient data were reconstructed from published Kaplan-Meier curves, and a pooled analysis of cumulative HCC incidence was performed using a random-effects model. RESULTS: We screened 5022 articles and included 18 studies (148,333 patients). In the pooled analysis, the cumulative incidence of HCC in alcohol-associated cirrhosis at 1, 5, and 10 years among studies that accounted for the competing risk of death without HCC was 1%, 3%, and 9%, respectively. A secondary analysis by traditional meta-analysis determined that the HCC incidence rate was higher in cohorts enrolled in a HCC surveillance program (18.6 vs 4.8 per 1000 person-years; P = .001) vs those who were not enrolled in a surveillance program. Meta-regression showed that diabetes, smoking, variceal bleeding, and hepatic decompensation were associated with a higher risk of HCC. CONCLUSIONS: Our analysis determined that the 5- and 10- year cumulative risk of HCC in alcohol-associated cirrhosis was 3% and 9%, respectively, with a higher incidence in cohorts that were enrolled in a HCC surveillance program. These data should be validated further in large prospective studies, and may have important implications for HCC screening and surveillance among patients with alcohol-associated cirrhosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Huang DQ, Tan DJH, Ng CH, et al. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022. PMID: 35940513. doi:10.1016/j.cgh.2022.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。